News
November 30, 2022 Event
Oblique Therapeutics is thrilled to take part to the next PLCF Event in France
6th December 2022- Paris
November 23, 2022 Event
Oblique Therapeutics is excited to be participating in the Biotechgate Digital Partnering event
Nov 28 - Dec 2, 2022 a great opportunity to establish new global connections!
November 11, 2022 Event
Oblique Therapeutics takes part to the 11th Drug Discovery Strategic Summit
November 10th-11th 2022 - Amsterdam - Netherland
November 9, 2022 News
Oblique Therapeutics is pleased to announce the nomination of Christer Nordstedt M.D. Ph.D. as Chief Executive Officer
the new CEO will assume the position on 1st December 2022.
October 18, 2022 Event
Oblique Therapeutics is looking forward to attend in-person the BIO Europe meeting October 24–26, 2022 | in Leipzig, Germany
We will also take part to the Bio Europe Virtual Event November 2–4, 2022.
September 29, 2022 Event
Oblique Therapeutics will be participating virtually in Bio Japan 2022
on 12th-14th October
September 20, 2022 Event
Oblique Therapeutics is attending next BioPharma America Boston
next 28-29 September 2022 In-person and Virtual Oct 4-5 2022
August 25, 2022 Event
Oblique Therapeutics will take part in the upcoming Biotechgate Digital Partnering
Virtual business development & licensing event | Aug 29 - Sep 2, 2022
July 28, 2022 News
REKRYTERING AV NY VD
July 8, 2022 News
North Point Securities agerade finansiell rådgivare i samband med
Oblique Therapeutics AB (publ.) Private Placement om cirka 28 MSEK.